Astrana Health, Inc. - Common Stock (ASTH)

Historical Holders from Q4 2017 to Q3 2025

Symbol: ASTH on Nasdaq
Type / Class: Equity / Common Stock
Shares outstanding: 49,931,653
All holders as of 30 Sep 2025: Q3 2025
Total 13F shares, excl. options: 26,740,469
Holdings value: $759,004,686
% of all portfolios: 0%
Number of holders: 184
Number of buys: 109
Number of sells: -78
Average buys %: +0%
Average sells %: -0%

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Significant Owners of Astrana Health, Inc. - Common Stock (ASTH)

Filer	Ownership	Change %	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
BlackRock, Inc.	12.4%	+9.09%	$191,646,870	-$6,109,882	6,234,446	-3.09%	BlackRock, Inc.	31 Mar 2025
ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSIONAL MEDICAL Corp	11%	-10%	$188,522,333	-$21,514,803	6,132,802	-10.2%	Allied Physicians of California, a Professional Medical Corporation	15 Feb 2025
VANGUARD GROUP INC	9.68%		$120,258,461		4,833,384		The Vanguard Group	30 Jun 2025

Institutional Holders of Astrana Health, Inc. - Common Stock (ASTH)

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Puts Notional Value	Calls Notional Value	Price	Investors
2025 Q3	26,740,469	$759,004,686	+$21,223,463	$929,880	$14,563,395	$28.35	184
2025 Q2	25,772,189	$641,392,329	-$15,342,979	$791,184	$12,865,448	$24.88	161
2025 Q1	26,257,633	$814,637,036	+$5,862,823	$3,135,111	$275,989	$31.01	168
2024 Q4	26,057,927	$822,017,819	+$3,128,832	$693,660	$13,006,125	$31.53	177
2024 Q3	25,295,709	$1,465,673,353	+$131,700,353	$984,980	$35,308,636	$57.94	186
2024 Q2	23,072,576	$935,815,210	+$22,763,995	$417,768	$1,208,688	$40.56	169
2024 Q1	22,756,494	$955,393,465	+$24,413,741	$806,208	$20,402,941	$41.99	158
2023 Q4	22,178,838	$849,210,903	+$26,256,665	$444,280	$1,895,850	$38.30	141
2023 Q3	21,503,159	$663,623,547	+$22,662,738	$144,995	$993,370	$30.85	132
2023 Q2	20,757,071	$656,229,537	+$22,212,849	$192,760	$3,782,520	$31.60	129
2023 Q1	20,034,782	$730,631,066	+$14,461,853	$189,644	$1,447,859	$36.47	131
2022 Q4	19,704,382	$583,144,207	-$13,404,604	$263,351	$618,431	$29.59	129
2022 Q3	19,814,272	$772,607,625	+$70,014,740	$1,350,000	$6,252,000	$39.00	148
2022 Q2	17,767,757	$685,808,256	+$18,274,263	$1,424,000	$2,671,000	$38.59	126
2022 Q1	17,609,470	$853,298,644	+$10,418,988	$1,604,000	$7,013,000	$48.47	129
2021 Q4	17,108,614	$1,256,730,970	+$26,349,379	$3,707,000	$13,678,000	$73.48	140
2021 Q3	16,644,270	$1,516,521,911	+$595,571,146	$7,466,000	$10,635,000	$91.05	137
2021 Q2	10,256,705	$644,299,364	+$260,959,544			$62.81	102
2021 Q1	6,359,542	$172,275,211	+$32,027,527			$27.09	75
2020 Q4	5,211,206	$95,222,607	+$2,906,278			$18.27	60
2020 Q3	5,058,422	$90,682,749	+$15,496,005			$17.94	62
2020 Q2	4,195,952	$69,229,389	+$12,105,432			$16.50	49
2020 Q1	3,507,141	$45,315,795	-$1,124,491			$12.92	49
2019 Q4	3,560,356	$65,544,872	-$36,902,879			$18.41	54
2019 Q3	5,569,591	$98,135,067	+$47,954,977			$17.62	46
2019 Q2	2,846,110	$47,557,190	+$8,339,757			$16.71	36
2019 Q1	2,387,347	$43,737,062	-$549,177			$18.33	37
2018 Q4	2,407,330	$47,779,685	+$851,599			$19.85	39
2018 Q3	2,283,686	$50,402,877	-$7,479,217			$22.07	36
2018 Q2	2,611,128	$67,524,947	+$58,395,475			$25.86	32
2018 Q1	541,971	$8,644,000	+$7,424,160			$15.95	13
2017 Q4	50,403	$1,209,000	+$1,209,000			$23.97	6